MGMTAI

Medical research services in the field of cancer treatment; providing medical research information, namely, using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.

Medical analysis of genomic and transcriptomic data using artificial intelligence to predict promoter methylation of the MGMT (O6-methylguanine-DNA methyltransferase ) gene and therapeutic response of cancers to related therapies.